Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

725 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype: A POPular Genetics Subanalysis.
Claassens DMF, Bergmeijer TO, Vos GJA, Hermanides RS, van 't Hof AWJ, van der Harst P, Barbato E, Morisco C, Tjon Joe Gin RM, Asselbergs FW, Mosterd A, Herrman JR, Dewilde WJM, Janssen PWA, Kelder JC, Mahmoodi BK, Deneer VHM, Ten Berg JM. Claassens DMF, et al. Among authors: barbato e. Circ Cardiovasc Interv. 2021 Apr;14(4):e009434. doi: 10.1161/CIRCINTERVENTIONS.120.009434. Epub 2021 Mar 16. Circ Cardiovasc Interv. 2021. PMID: 33722066
High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
Mangiacapra F, De Bruyne B, Muller O, Trana C, Ntalianis A, Bartunek J, Heyndrickx G, Di Sciascio G, Wijns W, Barbato E. Mangiacapra F, et al. Among authors: barbato e. JACC Cardiovasc Interv. 2010 Jan;3(1):35-40. doi: 10.1016/j.jcin.2009.10.024. JACC Cardiovasc Interv. 2010. PMID: 20129566 Free article.
Pressure-diameter relationship in human coronary arteries.
Muller O, Pyxaras SA, Trana C, Mangiacapra F, Barbato E, Wijns W, Taylor CA, De Bruyne B. Muller O, et al. Among authors: barbato e. Circ Cardiovasc Interv. 2012 Dec;5(6):791-6. doi: 10.1161/CIRCINTERVENTIONS.112.972224. Epub 2012 Dec 4. Circ Cardiovasc Interv. 2012. PMID: 23212396
Incremental Value of Platelet Reactivity Over a Risk Score of Clinical and Procedural Variables in Predicting Bleeding After Percutaneous Coronary Intervention via the Femoral Approach: Development and Validation of a New Bleeding Risk Score.
Mangiacapra F, Ricottini E, Barbato E, Demartini C, Peace A, Patti G, Vizzi V, De Bruyne B, Wijns W, Di Sciascio G. Mangiacapra F, et al. Among authors: barbato e. Circ Cardiovasc Interv. 2015 May;8(5):e002106. doi: 10.1161/CIRCINTERVENTIONS.114.002106. Circ Cardiovasc Interv. 2015. PMID: 25940521
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients).
Mangiacapra F, Panaioli E, Colaiori I, Ricottini E, Lauria Pantano A, Pozzilli P, Barbato E, Di Sciascio G. Mangiacapra F, et al. Among authors: barbato e. Circulation. 2016 Sep 13;134(11):835-7. doi: 10.1161/CIRCULATIONAHA.116.023743. Circulation. 2016. PMID: 27619717 Clinical Trial. No abstract available.
Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation).
Fearon WF, Nishi T, De Bruyne B, Boothroyd DB, Barbato E, Tonino P, Jüni P, Pijls NHJ, Hlatky MA; FAME 2 Trial Investigators. Fearon WF, et al. Among authors: barbato e. Circulation. 2018 Jan 30;137(5):480-487. doi: 10.1161/CIRCULATIONAHA.117.031907. Epub 2017 Nov 2. Circulation. 2018. PMID: 29097450 Clinical Trial.
725 results